Langerhans cell histiocytosis: A 16-year experience;Histiocitose das células de Langerhans: Experiência de 16 anos

Jornal de Pediatria

Volumn 83, Issue 1, 2007, Pages 79-86

  Campos, Márcia Kanadani ^a   Viana, Marcos Borato ^a   De Oliveira, Benigna Maria ^a   Ribeiro, Daniel Dias ^a   Silva, Cláudia Márcia De Resende ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Complications; Diagnosis; Langerhans cell histiocytosis; Therapy

Indexed keywords

ADOLESCENT; ARTICLE; BONE ATROPHY; CHILD; CLINICAL ARTICLE; DIABETES INSIPIDUS; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; INFANT; LYMPHADENOPATHY; MALE; MORTALITY; RECURRENCE RISK; RETROSPECTIVE STUDY; SKIN DEFECT; SURVIVAL RATE; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOLOGIC FACTORS; INFANT; MALE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33847047232     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1581     Document Type: Article

References (30)

1. Chu T, D'Angio GJ, Favara BE, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet. 1987;2:41-2.
2. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157-66.
3. Egeler RM, Annels NE, Hogendoorn PC. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation. Pediatr Blood Cancer. 2004;42:401-3.
4. Nezelof C, Basset F. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer. 2004;42:398-400.
5. Arceci RJ, Longley BJ, Emanuel PD. Atypical cellular disorders. Hematology Am Soc Hemat Educ Program. 2002;:297-314.
6. Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur J Cancer. 2004;40:1467-73.
7. Nicholson HS, Egeler RM, Nesbit ME. The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:379-84.
8. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr. 1995;127:1-11.
9. Broadbent V, Egeler RM, Nesbit ME Jr. Langerhans cell histiocytosis - clinical and epidemiological aspects. Br J Cancer Suppl. 1994;23:S11-6.
10. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:247-58.
11. Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol. 2001;37:108-14.
12. Histiocyte Society. Treatment protocol of the Third International Study for Langerhans Cell Histiocytosis. 2nd ed. Viena: Histiocyte Society; 2002.
13. Simms S, Warner NJ. A framework for understanding and responding to the psychosocial needs of children with Langerhans cell histiocytosis and their families. Hematol Oncol Clin North Am. 1998;12:359-67.
14. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr. 2001;138:728-34.
15. Viana MB, Oliveira BM, Silva CM, Rios Leite VH. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol. 1991;19:289-94.
16. Hamre M, Hedberg J, Buckley J, Bhatia S, Finlay J, Meadows A, et al. Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases. Med Pediatr Oncol. 1997;28:92-7.
17. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis study group. Arch Dis Child. 1996;75:17-24.
18. Azouz EM, Saigal G, Rodriguez MM, Podda A. Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol. 2005;35:103-15.
19. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (Histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76:2471-84.
20. Meyer JS, De Camargo B. The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:307-26.
21. Surico G, Muggeo P, Muggeo V, Conti V, Novielli C, Romano A, et al. Ear involvement in childhood Langerhans' cell histiocytosis. Head Neck. 2000;22:42-7.
22. Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:287-305.
23. Jubran RF, Marachelian A, Dorey F, Malogolowkin M. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005;45:37-42.
24. Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am. 1998;12:269-86.
25. Longaker MA, Frieden IJ, LeBoit, PE, Sherertz EF. Congenital "self-healing" Langerhans cell histiocytosis: the need for long-term follow-up. J Am Acad Dermatol. 1994;31:910-6.
26. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol. 1994;23:72-80.
27. Minkov M, Grois N, Arico, M, Braier J, Broadbent V, Donadieu J, et al. Preliminary results of the LCH - II trial of the Histiocyte Society. Med Pediatr Oncol. 2003;41:263.
28. Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. Klin Padiatr. 2000;212:139-44.
29. Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H, et al. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol. 2002;39:581-5.
30. Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society - Late effects study group. Pediatr Blood Cancer. 2004;42:438-44.